INmune Bio Statistics
NASDAQ: INMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.83-0.03 (-1.61%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
INmune Bio by the numbers
INmune Bio has a market capitalization of $50.8 million based on 27.75M shares outstanding. With trailing EPS of $-0.67, INmune Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.0% below its 50-day average and 11.7% above its 200-day average.
Average daily trading volume is 416.29K shares, or about $761,802 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INMB valuation vs. peer median
| Metric | INMB | Peer median | Difference |
|---|---|---|---|
| Market cap | $50.79M | $50.25M | +1% |
| Avg. volume | 416.29K | 13.51K | +2982% |
Peer median across 8 companies: CRBU, BKHA, LONA, BSEM, EXOZ, IMA, INKT, TVGN.
Valuation
- Market cap
- $50.79M
- EPS (TTM)
- $-0.67
- Shares outstanding
- 27.75M
Price and trading
- Previous close
- 1.86
- Open
- 1.85
- Day range
- 1.79 – 1.86
- 52-week range
- 1.09 – 2.60
- 52-week change
- -5.10%
- Beta
- —
- Volume
- 379.06K
- Average volume
- 416.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 50.79M
- Forward Pe
- -4.26
- Eps
- -0.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.60
- Week52 Low
- 1.09
- Avg Volume
- 416.29K
- Shares Outstanding
- 27.75M
- Ma50
- 2.13
- Ma200
- 1.64
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -29.62%
- Pct From52w Low
- 67.89%